A wide range of subsequent cohort studies consistently showed that worsening kidney function is accompanied by gradually higher FGF23 levels [39] and that an elevated circulating FGF23 level is associated with a higher mortality risk across stages of CKD [38, 40••] and in kidney transplant recipients [41–43]. The gene discussed is FGF23; the disease is chronic kidney disease.